---
title: "Sysmex Corporation (SSMXY.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SSMXY.US.md"
symbol: "SSMXY.US"
name: "Sysmex Corporation"
industry: "Health Care Equipment"
datetime: "2026-05-20T06:51:49.849Z"
locales:
  - [en](https://longbridge.com/en/quote/SSMXY.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SSMXY.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SSMXY.US.md)
---

# Sysmex Corporation (SSMXY.US)

## Company Overview

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, it offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; and lab assay services.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [www.sysmex.co.jp](https://www.sysmex.co.jp) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:15.000Z

**Overall: C (0.40)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 55 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -1.21% |  |
| Net Profit YoY | -33.60% |  |
| P/B Ratio | 1.70 |  |
| Dividend Ratio | 2.58% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 5383937221.25 |  |
| Revenue | 3294911779.40 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 7.32% | B |
| Profit Margin | 7.09% | B |
| Gross Margin | 51.14% | B |
| Revenue YoY | -1.21% | D |
| Net Profit YoY | -33.60% | D |
| Total Assets YoY | -0.27% | D |
| Net Assets YoY | 2.08% | C |
| Cash Flow Margin | 208.27% | B |
| OCF YoY | -1.21% | D |
| Turnover | 0.73 | B |
| Gearing Ratio | 28.53% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Sysmex Corporation",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-1.21%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-33.60%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.70",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "2.58%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "5383937221.25",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "3294911779.40",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "7.32%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "7.09%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "51.14%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "-1.21%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-33.60%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "-0.27%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "2.08%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "208.27%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "-1.21%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.73",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "28.53%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 23.04 | 23/183 | 28.85 | 20.66 | 18.62 |
| PB | 1.70 | 49/183 | 3.28 | 1.94 | 1.74 |
| PS (TTM) | 1.63 | 43/183 | 3.04 | 1.89 | 1.66 |
| Dividend Yield | 2.58% | 7/183 | 2.54% | 2.33% | 1.31% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | C | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | A | B | C | C | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/SSMXY.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/SSMXY.US/norm.md)
- [Related News](https://longbridge.com/en/quote/SSMXY.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/SSMXY.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**